Loading…
Alamar Biosciences, Inc. is projected to rise to $37.75 by 2027, a +33% move from its current price of $28.42. ALMR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $27.45 | $28.45 | $29.48 | +0.10% |
| Jul 15 | $27.07 | $28.47 | $29.95 | +0.19% |
| Jul 16 | $26.79 | $28.50 | $30.32 | +0.29% |
| Jul 17 | $26.57 | $28.53 | $30.64 | +0.38% |
| Jul 18 | $26.37 | $28.56 | $30.93 | +0.48% |
| Jul 19 | $26.19 | $28.58 | $31.19 | +0.58% |
| Jul 20 | $26.03 | $28.61 | $31.44 | +0.67% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $26.03 | $28.61 | $31.44 | +0.67% |
| Week 2 | $25.21 | $28.80 | $32.91 | +1.35% |
| Week 3 | $24.62 | $29.00 | $34.14 | +2.03% |
| Week 4 | $24.17 | $29.19 | $35.25 | +2.71% |
| Week 5 | $23.80 | $29.39 | $36.29 | +3.40% |
| Week 6 | $23.48 | $29.58 | $37.28 | +4.10% |
| Week 7 | $23.20 | $29.78 | $38.23 | +4.80% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Alamar Biosciences, Inc. is a proteomics company that develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. It develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers, and offers ARGO high throughput System, a fully automated precision proteomics platform.
The company’s offering supports biomarker analysis across discovery, translational research and diagnostics, and serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. It operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. It was incorporated in 2018 and is based in Fremont, California.
Alamar Biosciences, Inc. (ALMR) is currently trading at $26.87. The stock has a market cap of $1.86B and holds a rank of 2084. The 30-day price range is $20.55 to $35.14, with RSI14 at 70 and neutral overall sentiment.
The stock shows a near‑term support of $19.09 and resistance at $26.87. The forecast trajectory shows the average price advancing over time, with 2026 at $26.87 on average and a long‑term path to $711.33 by 2050, implying a potential ROI up to 2547.3% over the period.
A major floor 43.2% below — a decisive break under it would weaken the trend.
The nearest floor, 32.4% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 21.6% above — clearing it would confirm fresh momentum.
Key ALMR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ALMR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $26.22 | Buy | $26.73 | Buy |
| MA 10 | $26.47 | Buy | $26.04 | Buy |
| MA 20 | $24.41 | Buy | $24.87 | Buy |
| MA 50 | $22.87 | Buy | $23.47 | Buy |
| MA 100 | — | Neutral | — | Neutral |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 69.26 | Neutral |
| Stoch RSI (14) | 77.17 | Neutral |
| CCI (20) | 115.99 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.23 | Buy |
| ROC (12) | 23.89 | Buy |
| Bollinger %B (20,2) | 0.89 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.75 | Buy |
| Awesome (5,34) | 3.46 | Buy |
| Ultimate (7,14,28) | 67.81 | Neutral |
| Momentum (10) | 1.55 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 26.37 | Buy |
| ADX (14) | 21.58 | Buy |
| ATR (14) | 0.83 | Info |
The near‑term picture is neutral, with RSI at 70 indicating a balanced momentum. The stock’s price discovery sits between a defined range and key levels. Support is at $19.09 and resistance is at $26.87, framing the current trading context. The 30‑day range sits between $20.55 and $35.14, providing a broad corridor for price action in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.09 | $28.42 | $43.76 | 0% | Neutral | |
| $27.38 | $37.75 | $56.27 | +33% | Bullish | |
| $37.75 | $55.31 | $87.88 | +95% | Bullish | |
| $49.17 | $75.91 | $126.63 | +167% | Bullish | |
| $50.65 | $81.99 | $142.39 | +189% | Bullish | |
| $57.13 | $96.67 | $173.78 | +240% | Bullish | |
| $61.01 | $107.68 | $199.61 | +279% | Bullish | |
| $61.12 | $112.35 | $214.06 | +295% | Bullish | |
| $73.13 | $139.87 | $273.23 | +392% | Bullish | |
| $82.80 | $164.64 | $329.11 | +479% | Bullish | |
| $126.18 | $280.39 | $616.05 | +887% | Bullish | |
| $337.18 | $749.30 | $1,723.39 | +25.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $19.09 | $28.42 | $36.62 | +0.00% |
| August 2026 | $25.74 | $31.18 | $39.34 | +9.73% |
| September 2026 | $25.24 | $31.01 | $39.95 | -0.56% |
| October 2026 | $25.71 | $31.98 | $41.92 | +3.13% |
| November 2026 | $26.47 | $33.27 | $44.24 | +4.03% |
| December 2026 | $25.59 | $32.48 | $43.76 | -2.38% |
Click any year to see its month-by-month ALMR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ALMR is projected to trade between $19.09 and $43.76, averaging $28.42 — a potential gain of 0% from today's $28.42. A consolidation phase looks the most probable path here.
Alamar Biosciences, Inc.'s 2027 outlook centres on $37.75, within a $27.38 to $56.27 range. That is up +33% on the projected 2026 average. That marks a +33% change versus current levels. Momentum favours further upside here.
By 2028, ALMR could reach as high as $87.88, with a base case around $55.31 and support toward $37.75 — roughly +95% from $28.42. Buyers look set to stay in control over this stretch.
Expect ALMR to range from $49.17 to $126.63 through 2029. The $75.91 average target implies a +167% move from current prices. That is up +37% on the projected 2028 average. Momentum favours further upside here.
The ALMR price prediction for 2030 points to an average of $81.99 (low $50.65, high $142.39) — a potential gain of +189% on today's $28.42. Buyers look set to stay in control over this stretch.
In 2031, ALMR is projected to trade between $57.13 and $173.78, averaging $96.67 — a potential gain of +240% from today's $28.42. That is up +18% on the projected 2030 average. Momentum favours further upside here.
Alamar Biosciences, Inc.'s 2032 outlook centres on $107.68, within a $61.01 to $199.61 range. That is up +11% on the projected 2031 average. That marks a +279% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, ALMR could reach as high as $214.06, with a base case around $112.35 and support toward $61.12 — roughly +295% from $28.42. Momentum favours further upside here.
Expect ALMR to range from $73.13 to $273.23 through 2034. The $139.87 average target implies a +392% move from current prices. That is up +24% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The ALMR price prediction for 2035 points to an average of $164.64 (low $82.80, high $329.11) — a potential gain of +479% on today's $28.42. Momentum favours further upside here.
In 2040, ALMR is projected to trade between $126.18 and $616.05, averaging $280.39 — a potential gain of +887% from today's $28.42. That is up +70% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Alamar Biosciences, Inc.'s 2050 outlook centres on $749.30, within a $337.18 to $1,723.39 range. That is up +167% on the projected 2040 average. That marks a +25.4x change versus current levels. Momentum favours further upside here.
Investing $1,000 in ALMR today (≈ 35.186488 ALMR) could be worth
$26,365.17
+$25,365.17 (+2537%) by 2050 · US Dollar
Based on the average projected ALMR price of $749.3 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ALMRwould be worth at today's price.
$1,000 invested in ALMR on Apr 17, 2026 (≈ 45.454545 ALMR) would be worth
$1,291.82
+$291.82 (+29.2%) today · 1.29× · US Dollar
Based on a ALMR entry price of $22 vs. today's $28.42.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $25.94 | $1,095.61 | +9.6% |
| 1 month ago | $21.51 | $1,321.25 | +32.1% |
| All time ago | $22 | $1,291.82 | +29.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ALMR forecast.
Our base-case forecast reaches $57.00 around 2029.
Implied market cap at $57.00: $3.95B
The year‑by‑year forecast shows a reset from a 2026 average of $26.87 (min $19.09, max $41.41) to a bullish arc in subsequent years. By 2027 the average is projected at $36.74 with a 36.7% ROI, rising further to an average of $80.59 by 2030 (ROI 199.9%). The long horizon remains bullish, with 2040 at an average of $270.12 (ROI 905.3%) and 2050 at an average of $711.33 (ROI 2547.3%).
Across these years the sentiment remains bullish after 2026. These figures are estimates and not guarantees, and actual results may vary.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $80.59, with a min of $46.80 and a max of $146.76, and a projected ROI of 199.9%. The sentiment is bullish.
The forecast indicates bullish sentiment from 2027 onward, with the average rising to higher levels and ROI projections up to 2547.3% by 2050. These are estimates, not guarantees, and actual results may vary.
Yes, the long‑term forecast shows a max of $1,636.07 by 2050, indicating potential upside beyond $1,000 under the stated assumptions.
Current price is $26.87 and market cap is $1.86B.
2026: min $19.09, avg $26.87, max $41.41; 2027: min $25.80, avg $36.74, max $56.69; 2028: min $35.15, avg $53.75, max $88.89; 2029: min $45.00, avg $73.20, max $127.63; 2030: min $46.80, avg $80.59, max $146.76.
Alamar Biosciences, Inc. Community Discussion
0Share your Alamar Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.